Although its mechanism of action on osteoblasts and MM cells remains uncertain, this oligopeptide sequesters DKK1 from LRP5/6 and reduces tumor cell growth, providing an option for managing tumor burden in MM (Park et al., 2017). This evidence concerns the gene DKK1 and neoplasm.